- Home
- BCAB vs SPHL Comparison
BCAB vs SPHL Comparison
Compare BCAB & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | SPHL |
|---|---|---|
| Founded | 2007 | 2002 |
| Country | United States | Singapore |
| Employees | N/A | 73 |
| Industry | Medicinal Chemicals and Botanical Products | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCAB | SPHL |
|---|---|---|
| Price | $3.67 | $2.80 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 48.4K | ★ 2.1M |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.35 |
| 52 Week High | $6.52 | $25.11 |
Technical Indicators
Market Signals| Indicator | BCAB | SPHL |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 46.36 |
| Support Level | $3.24 | $2.24 |
| Resistance Level | $6.33 | $3.08 |
| Average True Range (ATR) | 0.37 | 0.83 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 45.46 | 8.24 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs. The company's operations are organized on a single reportable segment, which includes all activities related to the discovery, development, and commercialization of its CAB products.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.